Anju provides end-to-end software solutions that help customers manage mission-critical pharma processes and turn data into actionable insights.
Anju Software is a leading provider of comprehensive software solutions to the life sciences industry. Anju provides an integrated platform spanning clinical operations, medical affairs and commercial divisions including integrated data intelligence. Anju has combined deep industry and software domain expertise to build a next generation platform for the life sciences sector that can scale to provide solutions that meet customers’ needs from “molecule to retirement”.
Anju provides end-to-end software solutions that help customers manage mission-critical pharma processes and turn data into actionable insights. Anju’s philosophy is to support and guide clients over the long term in meeting their evolving software needs. Anju’s mission is to complement its strong product offering with exceptional customer support and delivering true quantifiable value.
Anju solutions are used by large and small pharmaceutical companies, clinical research organizations (CRO), full service agencies and medical device companies. Data flow between our systems, seamless communication with third party systems and AI-based data mining solutions provide a unique way for our customers to leverage critical information throughout their ecosystem.
Anju is a portfolio company of Abry Partners which is one of the most experienced and successful sector-focused private equity investment firms in North America. Since their founding in 1989, the firm has completed over $80 billion of leveraged transactions and other private equity or preferred equity placements. Currently, the firm manages over $5.0 billion of capital across their active funds.